Why GLP-1 weight loss plateaus — and why it is usually not the drug "stopping working"
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work mostly by turning appetite down. The first months on a rising dose are when that effect is strongest and the loss is fastest. Once the dose is stable, the body settles into the new appetite and the deficit it creates shrinks — not because the medication wore off, but because you now weigh less and eat about what that lighter body burns. In the trials behind these drugs the curve flattens for most people somewhere in the second half of the first year; that flattening is the expected shape, not a failure.
Two things make GLP-1 plateaus different from ordinary ones. First, under-eating is the risk rather than over-eating: with appetite suppressed it is easy to drift to very low intake and especially low protein without noticing, and low protein in a deficit means the pounds lost include muscle. Second, the scale can move in steps around dose changes, which makes two-week comparisons misleading. A trend line through a month of readings is the only honest way to see what is happening.
What this calculator checks that a generic one does not
It fits a least-squares trend through your weigh-ins and applies the same plateau definition as our main calculator: flat for three weeks or more is a plateau, two flat weeks is "too early to call". Then it adds three GLP-1 specific reads.
A fast-loss guard. If the trend shows sustained loss of 3 lb (1.36 kg) a week or more while on the medication, the result is a prompt to talk to your prescriber this week rather than any suggestion to keep going. That threshold is the one the NanoRhino coach uses for members on a GLP-1.
A protein check first. Protein at 1.2 to 1.6 g per kilogram of body weight is the single lever that decides whether the loss is fat or muscle, and on a GLP-1 it is the one most often missed. If you leave protein blank or enter a number under 1.2 g/kg, it goes to the top of your list.
A dose-stability note. If you have been on a stable dose for two months or more, the calculator says what the flattening most likely is — the appetite effect settling — and keeps the advice where it belongs: tracking, protein and strength work. It never suggests a dose, a change in dose, or stopping; those are decisions for your prescriber.
Your burn then and now comes from the same engine as our GLP-1 calorie and protein calculator: Mifflin-St Jeor resting rate plus activity, calibrated against members whose real burn we measured. The new calorie target it shows is an honest one — the pace it quotes is the pace that target can actually deliver, and it never goes below the safety floor.
What to do when the GLP-1 scale stalls
Get protein up before anything else. Hit the range the calculator gives you, spread across three or four small meals; on a suppressed appetite that usually means leading each meal with the protein and eating it first.
Add resistance training if it is not there. Two short strength sessions a week is the dose that tells the body to keep muscle. Walking is good for you but does not send that signal.
Take a week of honest intake photos. On these medications the surprise is often how little you are eating, and a coach can only help with a real picture.
Then weigh daily and read the weekly average, and give any change three weeks before you judge it. If you are losing at 3 lb a week or more, or feel unwell, that is a conversation with your prescriber, not with a calculator.
Frequently asked questions
- Why am I not losing weight on Ozempic / Wegovy anymore?
- Most often because the appetite effect has settled at a stable dose and you now eat about what your lighter body burns. The calculator shows how far your burn has dropped since you started and whether your trend is truly flat or just noisy. Dose questions go to your prescriber.
- Why did Mounjaro / Zepbound stop working for me?
- It usually has not stopped; the deficit it created has closed as you lost weight, and the scale is moving in smaller steps that are hard to see week to week. A month of weigh-ins through this calculator tells you whether the trend is flat, still down, or turning.
- How much protein should I eat on a GLP-1?
- About 1.2 to 1.6 g per kilogram of body weight per day — for a 200 lb (91 kg) person, roughly 110 to 145 g. The calculator gives your range and, if you entered a protein number, says whether you are under it.
- Is losing 3 pounds a week on a GLP-1 too fast?
- Sustained loss at 3 lb a week or more is faster than is usually safe for muscle, and the calculator will tell you to talk to your prescriber this week rather than suggest any change itself.
- Does this tool tell me whether to change my dose?
- No, and it never will. Dosing is a medical decision between you and your prescriber. This tool only looks at your weigh-ins, intake, protein and activity.
- Does the calculator work for compounded semaglutide or tirzepatide?
- Yes — the trend math and the protein and burn estimates do not depend on the brand. Select the matching molecule, or "other" if it is a different GLP-1.
- What happens after the result?
- You can talk it through with the NanoRhino AI coach on the page — a few minutes, no signup. If you want the same coaching every day, it continues over text and is built to complement a GLP-1: protein first, honest tracking, and a calorie target that updates as you lose. $10 per pound lost, capped at $500.
Sources
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021.
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022.
- Mifflin MD et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990.
- Hall KD et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011.